BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo JH, Zhang HY, Gao S, Zhang PJ, Li XT, Chen H, Wang XD, Zhu X. Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis. World J Gastroenterol 2017; 23(8): 1406-1411 [PMID: 28293087 DOI: 10.3748/wjg.v23.i8.1406] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Chen Y, Qiu C, Ma X, Lei K, Cai G, Liang X, Liu J. 17-allylamino-17-demethoxygeldanamycin impeded chemotherapy through antioxidant activation via reducing reactive oxygen species-induced cell death. J Cell Biochem 2018. [PMID: 30378153 DOI: 10.1002/jcb.27397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Shao W, Li C, Tang J, Song J, Li Z, Sun J, Xu Y, Zheng Z, Cao J, Zhang L. Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma. Cancer Manag Res 2019;11:9863-9. [PMID: 31819623 DOI: 10.2147/CMAR.S217524] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhu L, Zheng N, Li X, Zhang X. Hepatic Artery and Peripheral Vein Pharmacokinetics of Raltitrexed in Swine After the Administration of a Hepatic Arterial Infusion. Curr Drug Metab 2019;20:601-8. [PMID: 31237202 DOI: 10.2174/1389200220666190618100847] [Reference Citation Analysis]
4 Wei N, Zhang B, Wang Y, He XH, Xu LC, Li GD, Wang YH, Wang GZ, Huang HZ, Li WT. Transarterial chemoembolization with raltitrexed-based or floxuridine-based chemotherapy for unresectable colorectal cancer liver metastasis. Clin Transl Oncol 2019;21:443-50. [PMID: 30306400 DOI: 10.1007/s12094-018-1942-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
5 Gong Q, Song C, Wang X, Wang R, Cai G, Liang X, Liu J. Hyperthermic intraperitoneal chemotherapy with recombinant mutant human TNF-α and raltitrexed in mice with colorectal-peritoneal carcinomatosis. Exp Biol Med (Maywood) 2020;245:542-51. [PMID: 32041417 DOI: 10.1177/1535370220905047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Guadagni S, Clementi M, Mackay AR, Ricevuto E, Fiorentini G, Sarti D, Palumbo P, Apostolou P, Papasotiriou I, Masedu F, Valenti M, Giordano AV, Bruera G. Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study. J Cancer Res Clin Oncol. 2020;146:1273-1290. [PMID: 32088781 DOI: 10.1007/s00432-020-03156-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Ghiringhelli F, Vincent J, Bengrine L, Borg C, Jouve JL, Loffroy R, Guiu B, Blanc J, Bertaut A. Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study. J Cancer Res Clin Oncol 2019;145:2357-63. [DOI: 10.1007/s00432-019-02970-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Ramadan RA, Moghazy TF, Hafez R, Morsi H, Samir M, Shamesya M. Significance of expression of pyrimidine metabolizing genes in colon cancer. Arab J Gastroenterol 2020;21:189-93. [PMID: 32830091 DOI: 10.1016/j.ajg.2020.07.006] [Reference Citation Analysis]
9 Shao G, Liu R, Ding W, Lu L, Li W, Cao H, Liu R, Li C, Xiang H, Yang Z, Yang J, Song J, Wang J. Efficacy and safety of raltitrexed-based transarterial chemoembolization for colorectal cancer liver metastases. Anticancer Drugs 2018;29:1021-5. [PMID: 30134285 DOI: 10.1097/CAD.0000000000000690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chapelle N, Matysiak-Budnik T, Douane F, Metairie S, Rougier P, Touchefeu Y. Hepatic arterial infusion in the management of colorectal cancer liver metastasis: Current and future perspectives. Dig Liver Dis. 2018;50:220-225. [PMID: 29290599 DOI: 10.1016/j.dld.2017.12.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
11 Gallois C, Hafliger E, Auclin E, Perret A, Coutzac C, Turpin A, Pellat A, Randrian V, Basile D, Faroux R, Pernot S, Locher C, Hautefeuillle V, Dubreuil O, Palmieri LJ, Dior M, Artru P, Taieb J. First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre study. Dig Liver Dis 2021:S1590-8658(21)00456-4. [PMID: 34470724 DOI: 10.1016/j.dld.2021.08.009] [Reference Citation Analysis]
12 Zhu LZ, Xu S, Qian HL. Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus. World J Gastroenterol 2018; 24(23): 2501-2507 [PMID: 29930471 DOI: 10.3748/wjg.v24.i23.2501] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
13 Qi C, Gao H, Li S, Zong H, Hao H, Zhang L. A Case-Control Study on the Correlation Between Thymidylate Synthase Gene Polymorphisms and Raltitrexed Treatment Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Treatment. Genet Test Mol Biomarkers 2020;24:156-64. [PMID: 32101052 DOI: 10.1089/gtmb.2019.0111] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]